These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8947981)

  • 41. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.
    Prandoni P; Carnovali M; Marchiori A;
    Arch Intern Med; 2004 May; 164(10):1077-83. PubMed ID: 15159264
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Weight-based heparin dosing: clinical response and resource utilization.
    Lackie CL; Luzier AB; Donovan JA; Feras HI; Forrest A
    Clin Ther; 1998; 20(4):699-710. PubMed ID: 9737830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism.
    Wells PS; Forgie MA; Simms M; Greene A; Touchie D; Lewis G; Anderson J; Rodger MA
    Arch Intern Med; 2003 Apr; 163(8):917-20. PubMed ID: 12719200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activated partial thromboplastin time (aPTT) monitoring to achieve therapeutic anticoagulation before and after introducing a nomogram for adjunctive heparin treatment with thrombolytic therapy for acute myocardial infarction.
    Chamuleau SA; de Winter RJ
    Int J Cardiol; 1998 Dec; 67(3):241-6. PubMed ID: 9894705
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heparin therapy in pediatric patients: a prospective cohort study.
    Andrew M; Marzinotto V; Massicotte P; Blanchette V; Ginsberg J; Brill-Edwards P; Burrows P; Benson L; Williams W; David M
    Pediatr Res; 1994 Jan; 35(1):78-83. PubMed ID: 8134203
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin.
    Anand S; Ginsberg JS; Kearon C; Gent M; Hirsh J
    Arch Intern Med; 1996 Aug 12-26; 156(15):1677-81. PubMed ID: 8694666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Subcutaneous unfractionated heparin for the treatment of venous thromboembolism.
    Kearon C
    Curr Opin Pulm Med; 2007 Sep; 13(5):398-402. PubMed ID: 17940484
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An evaluation of empiric vs. nomogram-based dosing of heparin in an intensive care unit.
    Brown G; Dodek P
    Crit Care Med; 1997 Sep; 25(9):1534-8. PubMed ID: 9295828
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nurse-driven intravenous heparin protocol: quality improvement initiative.
    Williams TD; Sullivan K; Lacey C; Adoryan S; Watts B
    AACN Adv Crit Care; 2010; 21(2):152-61. PubMed ID: 20431444
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heparin administration via nomogram versus a standard approach in venous and arterial thromboembolic disease.
    Jaff MR; Olin JW; Piedmonte M; Pirzada C; Young JR
    Vasc Med; 1996; 1(2):97-101. PubMed ID: 9546934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved Anticoagulation with a Weight-Adjusted Heparin Nomogram in Patients with Acute Coronary Syndromes: A Randomized Trial.
    Hassan WM; Flaker GC; Feutz C; Petroski GF; Smith D
    J Thromb Thrombolysis; 1995; 2(3):245-249. PubMed ID: 10608031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation of a weight-based nomogram for the use of intravenous heparin in transient ischemic attack or stroke.
    Toth C; Voll C
    Stroke; 2002 Mar; 33(3):670-4. PubMed ID: 11872885
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacy-managed, weight-based heparin protocol.
    Rivey MP; Peterson JP
    Am J Hosp Pharm; 1993 Feb; 50(2):279-84. PubMed ID: 8480784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Utility of a weight-based heparin nomogram for patients with acute coronary syndromes.
    Zimmermann AT; Jeffries WS; McElroy H; Horowitz JD
    Intern Med J; 2003; 33(1-2):18-25. PubMed ID: 12534874
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Weight-based heparin dosing is more effective in the treatment of postoperative deep vein thrombosis.
    Linke LC; Katthagen BD
    Arch Orthop Trauma Surg; 1999; 119(3-4):208-11. PubMed ID: 10392521
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Subcutaneous heparin-calcium therapy: clinical and laboratory experience].
    Boda Z; Rák K
    Orv Hetil; 1989 Oct; 130(44):2347-9. PubMed ID: 2812763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Description and Evaluation of the Implementation of a Weight-Based, Nurse-Driven Heparin Nomogram in a Tertiary Academic Medical Center.
    Schurr JW; Stevens CA; Bane A; Luppi C; Culbreth SE; Miller AL; Connors JM; Sylvester KW
    Clin Appl Thromb Hemost; 2018 Mar; 24(2):248-253. PubMed ID: 28774195
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of initial heparin infusion rates for a high-dose protocol.
    Smith A; Stock EM; Fewel N; Rose M; Griffiths CL
    J Thromb Thrombolysis; 2014 May; 37(4):419-26. PubMed ID: 23892474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improved methods for estimating initial heparin infusion rates.
    Chenella FC; Gill MA; Kern JW; Floyd RA; McGehee WG
    Am J Hosp Pharm; 1979 Jun; 36(6):782-4. PubMed ID: 463894
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Developing and testing a system to improve the quality of heparin anticoagulation in patients with acute cardiac syndromes.
    Mungall D; Lord M; Cason S; Treadwell P; Williams D; Tedrick D
    Am J Cardiol; 1998 Sep; 82(5):574-9. PubMed ID: 9732882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.